Eli Lilly to build $5 billion Virginia facility to boost production of targeted cancer drugs, other treatments
1. Eli Lilly invests $5 billion in Virginia for cancer drug manufacturing. 2. This is part of a $27 billion U.S. manufacturing expansion. 3. New plant will produce bioconjugate drugs, enhancing pipeline growth. 4. Facility brings 650 new jobs and 1,800 construction positions. 5. Investments target growth beyond diabetes and obesity treatments.